June 4, 2020 / 8:41 AM / a month ago

BRIEF-AlzeCure: Positive Data From Clinical Study With ACD856

June 4 (Reuters) - AlzeCure Pharma AB:

* ALZECURE ANNOUNCES POSITIVE DATA FROM CLINICAL STUDY WITH ACD856

* PREPARATIONS ARE ONGOING TO INITIATE FURTHER CLINICAL TRIALS, WITH A PLANNED START BY END OF 2020

* RESULTS DEMONSTRATE ACD856 HAS GOOD PHARMACOKINETIC PROFILE WITH SIGNIFICANTLY SHORTER HUMAN HALF-LIFE THAN ITS PREDECESSOR AS WELL AS SUITABILITY FOR FURTHER CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below